Allied Market Research

2024

Rapid Influenza Diagnostic Test (ridt) Market

Rapid Influenza Diagnostic Test (RIDT) Market Size, Share, Competitive Landscape and Trend Analysis Report by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Rapid influenza diagnostic tests (RIDTs) are immunoassays which enable the identification of the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. The RIDTs have gained traction over the years owing to the advantages offered by these tests such as quick access to the result in less than approximately 15 minutes, and is easy to perform.

The RIDTs are highly utilized in the clinical decision making as the assist in the diagnostic and treatment decisions for patients in clinical settings. The factors that fuel the growth of the global rapid influenza diagnostic tests (RIDTs) market are escalating incidence of influenza, increasing focus in research funding for influenza diagnostics, and rising demand for rapid diagnosis and control of influenza. However, variability in sensitivity as well as specificity among influenza diagnostic tests, along with unstable regulatory framework regrading approval of new diagnostic tests restrain the market growth. Moreover, emerging advanced influenza diagnostics tests in the market is anticipated to offer lucrative opportunities for the expansion of the market.

The market is segmented on the basis of end user, and region. Based on end user, the market is segmented into hospitals & clinics, laboratories, and other. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key players that operate in the market are Thermo Fisher Scientific, Roche Diagnostics, Alere Inc., Quidel Corporation, Becton, Dickinson and Company, DiaSorin, SA Scientific Ltd., Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser AG), and Luminex Corporation.

Key Benefits

  • The study provides an in-depth analysis of the global RIDTs market with current trends and future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
  • Key players have been profiled and their strategies thoroughly analyzed, which predicts the competitive outlook of the market.
  • By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Rapid Influenza Diagnostic Test (RIDT) Market Key Segments:

By End User

  • Hospitals & Clinics
  • Laboratories
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Argentina
    • Rest of LAMEA

Rapid Influenza Diagnostic Test (RIDT) Market Report Highlights

Aspects Details
icon_5
By End User
  • Hospitals and Clinics
  • Laboratories
  • Other
icon_6
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_7
Key Market Players

Alere Inc., Quidel Corporation, Thermo Fisher Scientific, Roche Diagnostics, DiaSorin, Becton, Dickinson and Company, Analytik Jena AG, Meridian Bioscience, Inc., SA Scientific Ltd., Luminex Corporation

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Rapid Influenza Diagnostic Test (RIDT) Market

Global Opportunity Analysis and Industry Forecast, 2023-2032